Home
/
Prestige Consumer Healthcare Inc.
/
Financials
/
Quarterly
Prestige Consumer Healthcare Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Prestige Consumer Healthcare Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Jun 30, 2018
$253.98M
Aug 2, 2018
Q1
2019
Jun 30, 2017
$256.57M
Aug 2, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$283.44M
Feb 5, 2026
Q2
2026
Sep 30, 2025
$274.11M
Nov 6, 2025
Q1
2026
Jun 30, 2025
$249.53M
Aug 7, 2025
Q3
2026
Dec 31, 2024
$290.32M
Feb 5, 2026
Q2
2026
Sep 30, 2024
$283.79M
Nov 6, 2025
Q1
2026
Jun 30, 2024
$267.14M
Aug 7, 2025
Q3
2025
Dec 31, 2023
$282.74M
Feb 6, 2025
Q2
2025
Sep 30, 2023
$286.32M
Nov 7, 2024
Q1
2025
Jun 30, 2023
$279.31M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$275.52M
Feb 8, 2024
Q2
2024
Sep 30, 2022
$289.27M
Nov 2, 2023
Q1
2024
Jun 30, 2022
$277.06M
Aug 3, 2023
Q3
2023
Dec 31, 2021
$274.47M
Feb 2, 2023
Q2
2023
Sep 30, 2021
$276.23M
Nov 3, 2022
Q1
2023
Jun 30, 2021
$269.18M
Aug 4, 2022
Q3
2022
Dec 31, 2020
$238.79M
Feb 3, 2022
Q2
2022
Sep 30, 2020
$237.42M
Nov 4, 2021
Q1
2022
Jun 30, 2020
$229.39M
Aug 5, 2021
Q3
2021
Dec 31, 2019
$241.55M
Feb 4, 2021
Q2
2021
Sep 30, 2019
$238.07M
Nov 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Dec 31, 2017
$270.62M
Feb 1, 2018
Q2
2018
Sep 30, 2017
$258.03M
Nov 2, 2017
Q1
2018
Jun 30, 2017
$256.57M
Aug 3, 2017
Q3
2018
Dec 31, 2016
$216.76M
Feb 1, 2018
Q2
2018
Sep 30, 2016
$215.05M
Nov 2, 2017
Q1
2018
Jun 30, 2016
$209.58M
Aug 3, 2017
Q3
2017
Dec 31, 2015
$200.20M
Feb 2, 2017
Q2
2017
Sep 30, 2015
$206.07M
Nov 3, 2016
Q1
2017
Jun 30, 2015
$192.13M
Aug 4, 2016
Q3
2016
Dec 31, 2014
$197.61M
Feb 4, 2016
Q2
2016
Sep 30, 2014
$181.27M
Nov 5, 2015
Q1
2016
Jun 30, 2014
$145.70M
Aug 6, 2015
Q3
2015
Dec 31, 2013
$144.87M
Feb 5, 2015
Q2
2015
Sep 30, 2013
$166.95M
Nov 6, 2014
Q1
2015
Jun 30, 2013
$142.51M
Aug 7, 2014
Q3
2013
Dec 31, 2012
$160.23M
Feb 7, 2014
Q2
2013
Sep 30, 2012
$161.86M
Nov 7, 2013
Q1
2013
Jun 30, 2012
$147.00M
Aug 1, 2013
Q3
2012
Dec 31, 2011
$106.25M
Feb 7, 2013
Q2
2012
Sep 30, 2011
$105.54M
Nov 7, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$46.70M
Feb 5, 2026
Q2
2026
Sep 30, 2025
$42.21M
Nov 6, 2025
Q1
2026
Jun 30, 2025
$47.47M
Aug 7, 2025
Q3
2026
Dec 31, 2024
$61.03M
Feb 5, 2026
Q2
2026
Sep 30, 2024
$54.38M
Nov 6, 2025
Q1
2026
Jun 30, 2024
$49.07M
Aug 7, 2025
Q3
2025
Dec 31, 2023
$53.05M
Feb 6, 2025
Q2
2025
Sep 30, 2023
$53.56M
Nov 7, 2024
Q1
2025
Jun 30, 2023
$53.28M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$51.95M
Feb 8, 2024
Q2
2024
Sep 30, 2022
$51.02M
Nov 2, 2023
Q1
2024
Jun 30, 2022
$55.27M
Aug 3, 2023
Q3
2023
Dec 31, 2021
$50.22M
Feb 2, 2023
Q2
2023
Sep 30, 2021
$45.33M
Nov 3, 2022
Q1
2023
Jun 30, 2021
$57.76M
Aug 4, 2022
Q3
2022
Dec 31, 2020
$40.87M
Feb 3, 2022
Q2
2022
Sep 30, 2020
$44.59M
Nov 4, 2021
Q1
2022
Jun 30, 2020
$43.71M
Aug 5, 2021
Q3
2021
Dec 31, 2019
$38.06M
Feb 4, 2021
Q2
2021
Sep 30, 2019
$33.25M
Nov 5, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$82.49M
Feb 5, 2026
Q2
2026
Sep 30, 2025
$79.67M
Nov 6, 2025
Q1
2026
Jun 30, 2025
$71.76M
Aug 7, 2025
Q3
2026
Dec 31, 2024
$91.96M
Feb 5, 2026
Q2
2026
Sep 30, 2024
$84.34M
Nov 6, 2025
Q1
2026
Jun 30, 2024
$72.05M
Aug 7, 2025
Q3
2025
Dec 31, 2023
$86.83M
Feb 6, 2025
Q2
2025
Sep 30, 2023
$88.25M
Nov 7, 2024
Q1
2025
Jun 30, 2023
$85.19M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$87.18M
Feb 8, 2024
Q2
2024
Sep 30, 2022
$84.38M
Nov 2, 2023
Q1
2024
Jun 30, 2022
$87.01M
Aug 3, 2023
Q3
2023
Dec 31, 2021
$82.59M
Feb 2, 2023
Q2
2023
Sep 30, 2021
$78.56M
Nov 3, 2022
Q1
2023
Jun 30, 2021
$91.34M
Aug 4, 2022
Q3
2022
Dec 31, 2020
$73.44M
Feb 3, 2022
Q2
2022
Sep 30, 2020
$72.90M
Nov 4, 2021
Q1
2022
Jun 30, 2020
$80.12M
Aug 5, 2021
Q3
2021
Dec 31, 2019
$76.40M
Feb 4, 2021
Q2
2021
Sep 30, 2019
$69.35M
Nov 5, 2020